https://www.tga.gov.au/resources/artg/428330
Australian Register of Therapeutic Goods (ARTG) information for VYLOY zolbetuximab 100 mg vial powder for concentrate for solution for infusion.
vyloyzolbetuximabmgvialpowder
https://www.biospace.com/astellas-to-present-positive-findings-from-phase-3-spotlight-trial-of-zolbetuximab-during-2023-asco-gi-cancers-symposium
Astellas Pharma today will present detailed results from the Phase 3 SPOTLIGHT trial evaluating first-line treatment with zolbetuximab.
astellaspresentpositivefindingsphase